TL;DR
Treatment choice is based on clinical situation, disease aggressivity, disease aggressivity, molecular status (in particular, MMR status) and patients' comorbidities, and treatment strategy depends on the duration of platinum-free interval.
AI-generated by Semantic Scholar
